Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2023 on Monday, March 4, 2024, After Close of U.S.-Based Financial Markets

SAN FRANCISCO, Feb. 26, 2024 /PRNewswire/ — Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the fourth quarter and year-ended December 31, 2023 on Monday, March 4, 2024, after the close of U.S.-based financial markets. Howard Robin, President and Chief…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks